Abstract:Importance: Depression is more prevalent in patients with dry eye disease (DED) than in the general population; however, the association between severity of DED and depression needs further evaluation. Objective: To investigate the association between depression and severity of DED symptoms and signs, including inflammatory markers. Design, setting, and participants: Secondary cross-sectional and longitudinal analysis performed in April to December 2020 of data from Dry Eye Assessment and Management (DREAM) study, a randomized clinical trial from October 2014 to July 2016 including patients with moderate to severe symptoms and signs of DED. Enrolled from 27 ophthalmology and optometry centers, both academic and private, in 17 US states, 535 patients were followed up for 1 year. Exposure: Participants screened positive for depression if they scored 42 or less on the Mental Component Summary (MCS) of the 36-Item Short Form Health Survey. Main outcomes and measures: Symptoms of DED were assessed by Ocular Surface Disease Index (OSDI) and Brief Ocular Discomfort Index (BODI) and signs assessed by tear film breakup time, Schirmer test, corneal and conjunctival staining, tear osmolarity, and meibomian gland dysfunction at baseline, 6 months, and 12 months. A composite severity sign score was calculated from all 6 signs. Inflammatory markers (cytokines in tears and HLA-DR expression by conjunctival surface cells) were measured for some trial participants. Features of DED were compared between participants with and without depression and adjusted for age, sex, race, visits, and baseline comorbidities. Results: Among the 535 participants, mean (SD) age was 58 (13.2) years, 434 participants (81%) were women, and 398 (74.4%) were White. Participants who screened positive for depression had worse DED symptoms by OSDI (effect size = 0.45, P < .001) and BODI (effect size = 0.46, P < .001) and composite DED sign score (effect size = 0.21, P = .006). Lower MCS score (ie, worse depression) was correlated with higher OSDI score (ie, worse DED symptoms) at baseline (Spearman ρ = -0.09, P = .03), 6 months (ρ = -0.20, P < .001), and 12 months (ρ = -0.21, P < .001). Inflammatory markers did not differ by depression status. Conclusions and relevance: Depression was associated with more severe dry eye symptoms and overall signs, suggesting that among patients with moderate to severe DED, those with depression may be likely to have more severe DED. These findings support consideration of depression as a comorbidity when managing patients with DED. Further study is needed to elucidate the relationship.

Anxiety and Depression in Dry Eye Patients During the COVID-19 Pandemic: Mental State Investigation and Influencing Factor Analysis

The Association Between Dry Eye Disease With Depression, Anxiety and Sleep Disturbance During COVID-19

Anxiety and depression levels and their influencing factors in community-dwelling patients with schizophrenia in China during the COVID-19 pandemic

Evaluation of dry eye disease symptomatology and mental health status among patients with different COVID-19 statuses

Prevalence of dry eye disease among Chinese high school students during the COVID-19 outbreak

Experience of Dry Eye Patients With Anxiety and Depression: A Qualitative Study

Dry eye disease in patients with depressive and anxiety disorders in Shanghai.

Impact of dry eye disease on psychological symptoms among Chinese doctoral students studying abroad

Relationship Between Dry Eye Disease and Emotional Disorder: The Mediating Effect of Health Anxiety

Prevalence of dry eye during the COVID-19 pandemic: A systematic review and meta-analysis

The Association of Dry Eye Disease Signs and Symptoms with Anxiety and Depression: an Observational Study

Association between ambient air pollution and dry eye symptoms among Chinese individuals during the COVID-19 pandemic: A national-based study

Depression and anxiety in dry eye disease: a systematic review and meta-analysis

Symptoms of Dry Eye Disease in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19).

Impact of the COVID-19 pandemic on eye strain and dry eye symptoms

Factors Influencing Depression and Mental Distress Related to COVID-19 Among University Students in China: Online Cross-sectional Mediation Study

Anxiety and Depression in Patients with Dry Eye Syndrome

Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic

Prevalence and Factors Associated with Depression and Anxiety of Hospitalized Patients with COVID-19

Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study

Prevalence of dry eye disease symptoms, associated factors and impact on quality of life among medical students during the pandemic